title: Use of GLP-1 receptor agonists in Prader-Willi Syndrome: report of six cases.
authors.affiliation: Corresponding author: Antonino Crinò, antonino.crino@opbg.net.
authors.forename: Danilo
authors.initials: D
authors.lastname: Fintini
authors.forename: Graziano
authors.initials: G
authors.lastname: Grugni
authors.forename: Claudia
authors.initials: C
authors.lastname: Brufani
authors.forename: Sarah
authors.initials: S
authors.lastname: Bocchini
authors.forename: Marco
authors.initials: M
authors.lastname: Cappa
authors.forename: Antonino
authors.initials: A
authors.lastname: Crinò
mesh_terms: D000328:Adult; D001786:Blood Glucose / Q000378:metabolism; D015992:Body Mass Index; D005260:Female; D000067757:Glucagon-Like Peptide-1 Receptor; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D011218:Prader-Willi Syndrome / Q000188:drug therapy*; D018027:Receptors, Glucagon / Q000819:agonists*; D055815:Young Adult
chemical_list: D001786:Blood Glucose; D000067757:Glucagon-Like Peptide-1 Receptor; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D018027:Receptors, Glucagon; C000593833:GLP1R protein, human; C517652:hemoglobin A1c protein, human